Same Indication

Montelukast vs Sars-Cov-2 Virus Spike Protein

Montelukast vs Sars-Cov-2 Virus Spike Protein: Overview

This comparison examines the pharmacological differences between Montelukast and Sars-Cov-2 Virus Spike Protein.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Montelukast — C35H36ClNO3S.

Molecular Weight: Montelukast — 586.1800 g/mol.

Type: Montelukast — Small molecule; Sars-Cov-2 Virus Spike Protein — Vaccine component.